Novel lentiviral vectors with mutated reverse transcriptase for mRNA delivery of TALE nucleases
about
Lentiviral vectors can be used for full-length dystrophin gene therapyImproved cell-penetrating zinc-finger nuclease proteins for precision genome engineeringmRNA transfection of a novel TAL effector nuclease (TALEN) facilitates efficient knockout of HIV co-receptor CCR5.Reactivation of Latent HIV-1 Expression by Engineered TALE Transcription Factors.Highly efficient in vitro and in vivo delivery of functional RNAs using new versatile MS2-chimeric retrovirus-like particles.Use of genome-editing tools to treat sickle cell disease.Viral and Synthetic RNA Vector Technologies and Applications.Retroviral Vectors for Cancer Gene Therapy.Novel AIDS therapies based on gene editing.The therapeutic landscape of HIV-1 via genome editingEliminating HIV-1 Packaging Sequences from Lentiviral Vector Proviruses Enhances Safety and Expedites Gene Transfer for Gene Therapy.Efficient delivery of nuclease proteins for genome editing in human stem cells and primary cells.Development of an AAV9 coding for a 3XFLAG-TALEfrat#8-VP64 able to increase in vivo the human frataxin in YG8R mice.Viral Vectors, Engineered Cells and the CRISPR Revolution.Ex vivo and in vivo genome editing: a regulatory scientific framework from early development to clinical implementation.Lentiviral vectors can be used for full-length dystrophin gene therapy.Transient Retrovirus-Based CRISPR/Cas9 All-in-One Particles for Efficient, Targeted Gene Knockout
P2860
Q33668822-BABF9863-E3E9-4C31-97D7-A12A622CAB32Q35161372-EFE8DEA4-4531-46E1-8908-429ABC928DD8Q35770689-361BEA83-FA4E-41BB-A459-4563C7D9B62CQ35942658-675F2ACA-6B99-4E8D-B49A-310F28E9FEE8Q36185032-DDD33B4E-E07C-4076-91B2-4EF528AA1671Q38850483-B60EBAD3-9A06-462A-AC64-9D214CF3A659Q38885624-49DBA856-41BD-4EEF-8146-234B8F8F54C7Q39094431-619D2562-AEA4-474E-84B4-77ECA50F50CAQ39140209-30444339-C4D7-4545-BF0B-52699B8B95BDQ39153976-08B90789-8B9E-46C5-B13A-244BDEA6EE3BQ40183063-2B786F3F-A4C7-453C-9FB0-CAE77C9C39A4Q40403124-CB66F948-5BD9-41BC-89BA-D053FEE2220FQ40798280-145E51CE-347D-49B7-91DF-B146AA81A309Q45874356-F1CC17CB-DF51-4193-98A6-075F960F88D3Q48529117-1AB753BE-1AAB-485C-B970-71381745354AQ53426367-EC62E36B-844E-475E-B58D-A2AC4D9E62D5Q57493531-C8010507-6D6B-405E-9112-6AA571DEC65D
P2860
Novel lentiviral vectors with mutated reverse transcriptase for mRNA delivery of TALE nucleases
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Novel lentiviral vectors with ...... RNA delivery of TALE nucleases
@ast
Novel lentiviral vectors with ...... RNA delivery of TALE nucleases
@en
Novel lentiviral vectors with ...... RNA delivery of TALE nucleases
@nl
type
label
Novel lentiviral vectors with ...... RNA delivery of TALE nucleases
@ast
Novel lentiviral vectors with ...... RNA delivery of TALE nucleases
@en
Novel lentiviral vectors with ...... RNA delivery of TALE nucleases
@nl
prefLabel
Novel lentiviral vectors with ...... RNA delivery of TALE nucleases
@ast
Novel lentiviral vectors with ...... RNA delivery of TALE nucleases
@en
Novel lentiviral vectors with ...... RNA delivery of TALE nucleases
@nl
P2093
P2860
P50
P356
P1433
P1476
Novel lentiviral vectors with ...... RNA delivery of TALE nucleases
@en
P2093
Belinda Berdien
Kristoffer Riecken
P2860
P2888
P356
10.1038/SREP06409
P407
P577
2014-09-18T00:00:00Z
P5875
P6179
1032927941